EDGAR Filing Documents for 0001354488-13-001185

Form 8-K - Current report:

SEC Accession No. 0001354488-13-001185

Filing Date

2013-03-14

Accepted

2013-03-14 16:44:49

Documents

Period of Report

2013-03-14

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	tbuff_8k.htm	8-K	30467
2	SECURITIES PURCHASE AGREEMENT	tbuff_ex101.htm	EX-10.1	268894
3	REGISTRATION RIGHTS AGREEMENT	tbuff_ex102.htm	EX-10.2	168971
4	SERIES A/B WARRANT	tbuff_ex103.htm	EX-10.3	112488
	Complete submission text file	0001354488-13-001185.txt		582141

Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8

Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540

Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31198 | Film No.: 13690975
SIC: 2834 Pharmaceutical Preparations